A prospective study of intrapulmonary fat accumulation in the newborn lung following intralipid infusion

Area of Science:

• Neonatal nutrition
• Parenteral nutrition safety
• Lipid emulsion stability

Background:

• Total parenteral nutrition (TPN) is crucial for infants unable to receive enteral nutrition.
• Parenteral fat emulsions are used in TPN to provide essential fatty acids and calories.
• The safety and stability of these emulsions, particularly in vulnerable infant populations, require careful evaluation.

Purpose of the Study:

• To assess the safety and stability of a parenteral fat emulsion (Intralipid) in neonatal total parenteral nutrition (TPN).
• To investigate potential adverse effects of Intralipid administration in infants compared to a dextrose-only regimen.

Main Methods:

• A study involving 29 infants receiving TPN with either a 25% Dextrose solution (Group I) or 10% Intralipid (Group II).
• Both groups received Vamin glucose and Dextrose electrolyte solution.
• Regular biochemical monitoring was conducted throughout the study period.

Main Results:

• No infants in either group exhibited lipemia or abnormally high free fatty acid levels.
• Eight infants died; lipid staining material was found in the pulmonary vessels of those who received Intralipid.
• One infant with low Intralipid infusion rates showed massive pulmonary fat accumulation despite normal pre-mortem biochemistry.

Conclusions:

• Parenteral fat emulsion (Intralipid) may pose risks in critically ill infants due to potential instability.
• Agglomeration of fat particles may occur in ill infants, leading to pulmonary deposition before metabolism.
• Further research is needed to understand the mechanisms of fat emulsion instability and deposition in vulnerable infant populations.